About Pharmesol
Pharmesol is a private company based in Coppell, Texas. It has reported $160,000 raised in two offerings on Form D since January 2023. Its chief executive is Siyeon Park.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Mar 18, 2025 | $0of $1.3M target | 0 | — | SAFEsRule 506(b) | Form D ↗ |
| Jan 10, 2023 | Jan 25, 2023 | $160,000of $300K target | 2 | $80,000 | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $160,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pharmesol's Form D filed Mar 18, 2025.
SP
Siyeon Park
CEO
Earlier filings also listed Saumya Rawat (director, last listed Jan 2023) and Evan Feldman (director, last listed Jan 2023).